CELYAD ONCOLOGY SA Other Operating Income Expense
CELYAD ONCOLOGY SA reported Other Operating Income Expense of -EUR 7.32 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:OtherOperatingIncomeExpense · last filed 2020-03-25
| Period end | Other Operating Income Expense 12 month | Other Operating Income Expense 12 month as first filed |
|---|---|---|
| 2018-12-31 | -7.32M EUR 20-F · filed 2019-04-05 | |
| 2017-12-31 | 2.59M EUR 20-F · filed 2020-03-25 | 2.59M EUR 20-F · filed 2018-04-06 |
| 2016-12-31 | 3.34M EUR 20-F · filed 2019-04-05 | |
| 2015-12-31 | 322.00K EUR 20-F · filed 2018-04-06 |